Back to Results
First PageMeta Content
Non-small-cell lung carcinoma / Large-cell lung carcinoma / Cancer staging / Small-cell carcinoma / Enolase 2 / Cancer / Breast cancer / Tumor marker / Carcinoembryonic antigen / Medicine / Oncology / Lung cancer


Tumor Markers in Lung Cancer
Add to Reading List

Document Date: 2008-02-15 16:19:24


Open Document

File Size: 203,04 KB

Share Result on Facebook

City

München / Barcelona / Gauting / Giessen / Tokyo / Heerlen / /

Company

Ken Yamaguchi8 / /

Continent

North America / /

Country

Germany / Netherlands / Japan / Spain / /

Currency

pence / /

/

Facility

Hospital Clin / National Cancer Center Research Institute / Atrium Medical Centre / /

IndustryTerm

treatment of small cell lung cancer / treatment of non-small cell lung cancer / therapy of lung cancer / treatment of NSCLC in advanced disease / diagnostic tool / /

MedicalCondition

advanced disease / early operable disease / lymphoma / liver dysfunction / sensitive tumor / appropriate tumor / dermatological diseases / neuroendocrine tumors / I disease / squamous tumors / small cell lung cancer / several tumor / hemoptysis / Diagnosis Tumor / SCLC / Squamous cell carcinoma antigen / tumor disease / non-small cell lung cancer / Renal disease / early stage disease / Lung Cancer Petra Stieber1 / squamous cell cancer / Guidelines And Recommendations For Use Of Tumor Markers In The Clinic Lung Cancer / benign lung diseases / post-therapeutic surveillance situation tumor / small cell lung cancer NSE / recurrent disease / squamous cancer / lung cancers / adenocarcinoma / residual tumor / tumor / squamous cell lung cancer / breast cancers / large cell carcinomas / squamous cell carcinoma / adenocarcinomas / limited stage disease / tumors / disease / NSCLC / lung tumors / extensive stage disease / IV disease / squamous tumor / benign diseases / Serum tumor / gastrointestinal and gynaecological cancers / Introduction Lung cancer / large cell carcinoma / progressive disease / inoperable lung cancer / pain / single tumor / histologically mixed tumor / early metastases / lung cancer / limited SCLC disease / nonsmall cell lung cancer / liver cancer / non-small cell adenocarcinoma / infectious diseases / predominantly squamous cell carcinomas / frequent cancer / benign and malignant diseases / cough / renal failure / metastases / adenocarcinoma and large cell lung cancer / particularly squamous cell tumors / seminoma / /

MedicalTreatment

chemo / cranial irradiation / combination chemotherapy / chemotherapy / radiotherapy / surgery / chemotherapies / /

Organization

Universität München / National Cancer Center Research Institute / Department of Pathology / Universitat Giessen / National Academy of Clinical Biochemistry Guidelines for the Use of Tumor Markers / Institute for Social Medicine / Atrium Medical Centre / Department of Clinical Biochemistry / National Academy of Clinical Biochemistry / /

Position

Chair *Sub-Committee / /

Product

carboplatin / etoposide / /

ProvinceOrState

Connecticut / /

Region

Northeastern Europe / /

Technology

tomography / MRI / chemotherapy / /

SocialTag